Is TALS or SCHD a better dividend investment in 2026?

TALS currently yields 55.51% with a 5% 5-year dividend growth rate. SCHD yields 3.44% with 13.05% growth. The better choice depends on your goal: TALS offers higher current income.

What is the dividend yield difference between TALS and SCHD?

TALS has a forward dividend yield of 55.51% ($1.51/share annually). SCHD yields 3.44% ($1.06/share annually). The yield gap is 52.07 percentage points.

Home › Compare › TALS vs SCHD

TALS vs SCHD: Dividend Comparison 2026

TALS yields 55.51% · SCHD yields 3.44%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TALS wins by $492.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

TALS

● Live price

55.51%

Share price

$2.72

Annual div

$1.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$521.6K

Annual income

$114,803.66

Full TALS calculator →

SCHD

Schwab U.S. Dividend Equity ETF

● Live price

3.44%

Share price

$30.68

Annual div

$1.06

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.0K

Annual income

$422.61

Full SCHD calculator →

Portfolio growth — TALS vs SCHD

📍 TALS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TALS	SCHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TALS + SCHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TALS pays

SCHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TALS

Annual income on $10K today (after 15% tax)

$4,718.75/yr

After 10yr DRIP, annual income (after tax)

$97,583.11/yr

SCHD

Annual income on $10K today (after 15% tax)

$292.49/yr

After 10yr DRIP, annual income (after tax)

$359.22/yr

At 15% tax rate, TALS beats the other by $97,223.89/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TALS + SCHD for your $10,000?

TALS: 50%SCHD: 50%

100% SCHD50/50100% TALS

Portfolio after 10yr

$275.3K

Annual income

$57,613.13/yr

Blended yield

20.93%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on TALS right now

TALS

Analyst Ratings

Buy

Hold

Consensus: Hold

Altman Z

5.6

Piotroski

1/9

SCHD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TALS buys

SCHD buys

No recent congressional trades found for TALS or SCHD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTALSSCHD

Forward yield	55.51% ✓	3.44%
Annual dividend / share	$1.51 ✓	$1.06
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$521.6K ✓	$29.0K
Annual income after 10y	$114,803.66 ✓	$422.61
Total dividends collected	$425.9K ✓	$3.9K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: TALS vs SCHD ($10,000, DRIP)

Year	TALS Portfolio	TALS Income/yr	SCHD Portfolio	SCHD Income/yr	Gap
1← crossover	$16,251	$5,551.47	$11,224	$344.10	+$5.0K → TALS
2	$25,821	$8,431.73	$12,567	$354.98	+$13.3K → TALS
3	$40,148	$12,520.17	$14,038	$365.30	+$26.1K → TALS
4	$61,153	$18,193.88	$15,648	$375.06	+$45.5K → TALS
5	$91,333	$25,899.34	$17,410	$384.27	+$73.9K → TALS
6	$133,877	$36,150.61	$19,335	$392.95	+$114.5K → TALS
7	$192,771	$49,523.37	$21,437	$401.10	+$171.3K → TALS
8	$272,910	$66,644.47	$23,733	$408.75	+$249.2K → TALS
9	$380,191	$88,177.34	$26,237	$415.91	+$354.0K → TALS
10	$521,608	$114,803.66	$28,968	$422.61	+$492.6K → TALS

TALS vs SCHD: Complete Analysis 2026

TALS — Stock

Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Its lead product candidate is FCR001, a novel allogeneic cell therapy that is in Phase II trial for living donor kidney transplant patients. The company is also developing FCR002 in deceased donor kidney transplants; FCR001 in patients with a severe form of scleroderma; and FCR001 for one or more severe non-malignant blood, immune, or metabolic disorders. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky.

Full TALS Calculator →

SCHD — ETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →

📬

Get this TALS vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TALS vs JEPI TALS vs O TALS vs KO TALS vs MAIN TALS vs VYM TALS vs DGRO TALS vs VIG TALS vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.